A federal judge in Texas ruled that three states can proceed with efforts to restrict access to the abortion drug mifepristone, making it harder to obtain.
The states of Idaho, Kansas, and Missouri have requested the FDA to limit telehealth prescriptions for mifepristone to the first seven weeks of pregnancy.
ACLU highlighted that Kacsmaryk's decision opens the door for further attacks on medication abortion and criticized the case for not having been settled earlier by the Supreme Court.
The intervention of states in this case reflects ongoing tensions between state and federal approaches to reproductive healthcare access, with implications for telehealth service provision.
Collection
[
|
...
]